TG Therapeutics Inc
TGTX
|
|
|
|
Trading Volume | 81,656 |
|
25.19 - 6.68 |
Market Cap Full | $ 3.6B |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | -0.2% | -11.4% | 27.1% | -50% |
Q2 | - | 21.2% | 65.2% | -55.3% |
Q3 | - | 18.9% | -66.3% | 39.3% |
Q4 | - | -2.2% | 109.3% | 99.8% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
-0.2 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
-4.9 | 6 | -12.1 | -6.2 | 14.8 | 9.8 | 10.5 | 18.9 | - | - | - | -13.5 |
2023 | |||||||||||
28.7 | 5.2 | -6.1 | 65.1 | 7.3 | -6.7 | -16.7 | -49.4 | -20.2 | -7.5 | 65.7 | 33.3 |
2022 | |||||||||||
-39.1 | -11.8 | -6.9 | -26.7 | -36.6 | -3.9 | 40.8 | 19.1 | -17 | -1.7 | 51.6 | 34.1 |
2021 | |||||||||||
-7.2 | -8.4 | 9.2 | -7.4 | -22.4 | 11.8 | -9.3 | -23 | 25.7 | -8.2 | -57.8 | 44.1 |
2020 | |||||||||||
25.1 | -18.7 | -13.7 | 19.5 | 58.6 | 4.5 | 0.5 | 26.7 | 7.9 | -3.9 | 14.1 | 77.3 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -0.3 | -0.5 | -0.7 | -0.5 |
Q2 | -0.3 | -0.3 | -0.6 | -0.5 |
Q3 | 0.7 | -0.3 | -0.7 | -0.7 |
Q4 | 0 | -0.4 | -0.7 | -0.7 |
A | 0.11 | -1.5 | -2.6 | -2.4 |